Factor | 3-year LRRFS | 3-year DMFS | 3-year DFS | 3-year OS | ||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | P* | HR (95% CI) | P* | HR (95% CI) | P* | HR (95% CI) | P* | |
Treatment pattern (P67.5 vs.P70) | 0.653 (0.249-1.714) | 0.387 | 0.682 (0.286-1.623) | 0.387 | 0.564 (0.310-1.024) | 0.060 | 0.476 (0.236-0.957) | 0.037 |
Gender (female vs. male) | 2.481 (0.927-6.644) | 0.071 | 0.279 (0.065-1.209) | 0.088 | 0.878 (0.431-1.791) | 0.721 | 0.765 (0.328-2.411) | 0.535 |
Age (≥50 vs. <50 years) | 2.672 (0.990-7.216) | 0.052 | 2.617 (1.076-6.364) | 0.034 | 3.058 (1.659-5.635) | 0.000 | 2.914 (1.434-5.921) | 0.003 |
T Stage (3–4 vs.1-2) | 2.715 (0.784-9.404) | 0.115 | 0.391 (0.105-1.453) | 0.161 | 1.196 (0.558-2.562) | 0.646 | 0.960 (0.382-2.411) | 0.931 |
Node category (N+ vs. N-) | 0.957 (0.172-5.328) | 0.960 | 1.891 (0.389-9.196) | 0.430 | 1.856 (0.607-5.681) | 0.278 | 1.542 (0.483-4.925) | 0.465 |
N Stage (2–3 vs. 0–1) | 1.423 (0.383-5.291) | 0.598 | 0.359 (0.085-1.515) | 0.163 | 0.801 (0.351-1.824) | 0.597 | 0.691 (0.255-1.872) | 0.467 |
UICC Stage (III-IV vs. I-II) | 4.031 (0.338-48.101) | 0.270 | 9.786 (1.448-66.128) | 0.019 | 4.487 (1.245-16.166) | 0.022 | 4.208 (1.026-17.263) | 0.046 |